Joel DudleyinInnovation EndeavorsOur investment in Weave Bio: Using AI to alleviate regulatory friction in drug developmentBy Joel Dudley and Nick OlsenJun 12Jun 12
Joel DudleyinInnovation EndeavorsOur investment in BioLoomics — evolving better antibody therapeuticsBy Joel Dudley and Nick OlsenSep 19, 2023Sep 19, 2023
Joel DudleyinInnovation EndeavorsTuning precision polypharmacology: our investment in Harmonic DiscoveryBy Joel Dudley and Nick OlsenSep 8, 2022Sep 8, 2022
Joel DudleyinInnovation EndeavorsAnnouncing our investment in Think BioscienceBy Joel Dudley and Nick OlsenAug 18, 2022Aug 18, 2022
Joel DudleyinInnovation EndeavorsFrom entrepreneur to investorWhy there’s never been a better time to invest in biotechnologyAug 17, 2022Aug 17, 2022
Joel DudleyinInnovation EndeavorsDeep Real-World Drug Discovery — Our Investment in Character BiosciencesBy Joel Dudley and Nick OlsenMay 17, 2022May 17, 2022